Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease
Clinical trial NCT04218084 · TERMINATED
Trial details
- NCT number
- NCT04218084
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2024-01-18
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.